As the beauty and cosmetics industry balances resilience with innovation, IPAR, EL and ELF stand out for their brand strength and strategic execution.

PARIS--(BUSINESS WIRE)--Balmain Beauty unveils Destin de Balmain, its debut prestige fragrance. The new feminine fragrance is a bold, floral fruity eau de parfum that captures the unstoppable energy of the Balmain woman: independent, youthful, and unapologetic. THE STORY: LIVE YOUR DESTINY Destin de Balmain is destiny you hold in your hands, a journey of optimism and infinite possibilities. The refillable fragrance unites those who express themselves without rules or expectations. Inspired by t.

After a stellar performance in 2025, Estée Lauder's stock does not appear to be overvalued. A choppy business recovery is to be expected, but this should not dissuade long-term investors. The stock's high market risk should be taken into account, as the equity market poses a threat for high-beta stocks.

Insight into Mark Hillman (Trades, Portfolio)'s Fourth Quarter 2025 Investment Moves Mark Hillman (Trades, Portfolio) recently submitted the 13F filing for the

EL expands the second-quarter fiscal 2026 gross margin by 40 basis points to 76.5% as PRGP savings and tighter inventory help offset tariff pressure.

Beirne Wealth Consulting Services LLC bought a new position in The Estee Lauder Companies Inc. (NYSE: EL) in the third quarter, according to the company in its most recent disclosure with the SEC. The fund bought 7,608 shares of the company's stock, valued at approximately $670,000. A number of other hedge funds have

Advisors Asset Management Inc. lowered its position in shares of The Estee Lauder Companies Inc. (NYSE: EL) by 21.4% in the undefined quarter, according to its most recent disclosure with the SEC. The fund owned 22,827 shares of the company's stock after selling 6,206 shares during the period. Advisors Asset Management Inc.'s holdings

Shareholders should contact the firm immediately as there may be limited time to enforce your rights.

Candriam S.C.A. lifted its stake in shares of The Estee Lauder Companies Inc. (NYSE: EL) by 168.8% in the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 38,966 shares of the company's stock after acquiring an additional 24,469 shares during the

Amazon (AMZN) acquires a 5.3% stake in BETA Technologies, sharply boosting BETA's premarket share price. Moderna (MRNA) faces an FDA refusal-to-file for its mRNA-1010 influenza vaccine, citing inadequate trial controls but no safety or efficacy issues.